MiRNA microarray kits and reagents market is experiencing robust growth driven by rising demand for precision diagnostics, biomarker discovery, and translational research. Expansion of oncology ...
This recall involves the replacement reagent #1 bottles sold with Taylor Phosphate Test Kits #K-1106 and also sold separately. The kits are used to test the level of phosphate in water for pools, spas ...
Illumina has been barred from exporting its DNA sequencers to China, which closed its doors to the company in response to the Trump administration expanding its tariffs on the country.
Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced a series of updates to its NovaSeq X Series, delivering the NovaSeq X single-flow-cell system alongside a ...
Illumina has begun rolling out a series of updates to its top-of-the-line DNA sequencer models, with the goal of making the high-throughput machines more attractive to smaller laboratories. For its ...
New NovaSeq X 25B 100-cycle and 200-cycle kits enhance multiomic capabilities on NovaSeq X, and enable newly released Illumina Single-Cell Prep SAN DIEGO, Jan. 7, 2025 /PRNewswire/ -- Illumina, Inc.
How Illumina's Erin Imsand and her team helped develop reagents that can be stored at room temperature Originally published on Illumina News Center Illumina recently launched the MiSeq i100 and MiSeq ...
FRANKLIN LAKES, N.J. - BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology firm, announced the commercial availability of a new series of high-throughput, robotics-compatible ...
San Diego-based Illumina, a global leader in genomic sequencing technology, unveiled its latest machines that could make analyzing genetics cheaper, more efficient and more accessible to researchers.
Bengaluru: Medical equipment maker Illumina announced on Wednesday its new series of smaller, low-cost benchtop gene sequencers, to make sequencing accessible to more research and testing labs. New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results